The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year

1999

Stage

Dead | Dead

About Xeren DataSystems

Xeren DataSystems develops Lattice, a digital asset storage, organization and publication application, which aims to allow the user to quickly and inexpensively consolidate animations and any other electronic media into easily distributed interactive educational modules. Xeren produces high quality web deliverables through alliances with the medical animation firm Animedix and the interactive multimedia firm Z-Order (www.z-order.net). Xeren DataSystems enjoys a growing list of commercial and academic clients, including Merck and Company, Aventis Pharmaceuticals, Cor Therapeutics, Millennium Pharmaceuticals, Fraunhofer USA, the Delaware Biotechnology Institute, Christiana Care Health System, the American College of Emergency Physicians, BMS (Squibb), and Wayne State University.

Xeren DataSystems Headquarter Location

1 Innovation Way Newark, DE 19747

Newark, Delaware, 19711,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

  • When was Xeren DataSystems founded?

    Xeren DataSystems was founded in 1999.

  • Where is Xeren DataSystems's headquarters?

    Xeren DataSystems's headquarters is located at 1 Innovation Way Newark, DE 19747, Newark.

  • What is Xeren DataSystems's latest funding round?

    Xeren DataSystems's latest funding round is Dead.

  • Who are the investors of Xeren DataSystems?

    Investors of Xeren DataSystems include Delaware Technology Park.

  • Who are Xeren DataSystems's competitors?

    Competitors of Xeren DataSystems include Biolog, PPD, Biocytogen, Clinipace, Portola Pharmaceuticals and 12 more.

You May Also Like

A
AgaPharm

AgaPharm is developing a prescription eye drop for Diabetics. The drug aims to offer a simple, low-cost treatment that can deliver a safe and effective dose to the eye, preventing or slowing down the onset of diabetic blindness and cataract. The company's Research Partner is the Biotechnology Research Institute at the National Research Council of the Government of Canada.

C
CELBIO SpA

SiTec Consulting was established in 1996, on the basis of long experience in pharmaceutical R&D. The company developed a range of expertise working with pharmaceutical and biotech companies in the United States and in Europe.n SiTec Consulting offers pharmaceutical and biotechnology companies a variety of services in the areas of preformulation, drug development, drug delivery and formulation technologies evaluation, regulatory and cGLP/cGMP compliance. The company can actively collaborate with start-up pharmaceutical and drug delivery companies to provide scientific and strategic support in the establishment of the new company's activities. The company emphasize open communication, active involvement with the client and continuous feedback.n Networking is one of the company's assets, allowing us to cover the complex demands of the R&D process. The company have access to laboratories and equipment and resources, located at the Bioindustry Park Canavese, and at selected universities and research centers in Europe. This aims to give the possibility to conduct and manage experimental parts of projects at the company's clients' request.n The company value the importance of high quality training. In addition to the hands-on experience the company can provide to the company's clients, SiTec is an authorized representative of the Center for Professional Advancement, a worldwide private institution dedicated to the provision of continuing technical and scientific education at a professional level.

A
Avestha Gengraine Technologies

Avestha Gengraine Technologies is a biotechnology & bioinformatics company, focusing on the convergence between food, pharmaceuticals and clinical genomics leading to preventive personalized medicine. . Avesthagen was founded by Dr. Villoo Morawala-Patell in 1998, on the premise that the time was ripe for India to establish its own research and discovery based biotechnology industry. Avesthagen aims to provide solutions for global challenges in agriculture & health problems in the areas of degenerative conditions, metabolic disorders and infectious diseases.

Biolog Logo
Biolog

Biolog specializes in microbial identification, phenotypic cell profiling, and metabolic fingerprinting for microbial and mammalian cells. The company’s products enable the identification of thousands of species of bacteria, yeast, and fungi, as well as the characterization of human cells and mitochondria. Biolog's products are available worldwide, either directly from the company or through its extensive network of international distributors. The company was founded in 1984 and is based in Hayward, California.

M
Martin-Protean

Martin-Protean is a biotechnology company that determines protein structure using chemical cross-linking and mass spectrometry. Its technology aims to provide insight into protein structure, facilitating drug design and discovery. Its products can be used by the pharmaceutical and biotechnology sectors as well as the NIH, national, and academic labs.

P
Provonix

Provonix is a contract research organization focused on providing individualized clinical trial solutions to meet the needs of pharmaceutical, biotechnology, and medical device companies.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.